Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 1/20 | 0.54 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.54 |
| ▸ | AXL | P30530 | 1/20 | 0.50 |
| ▸ | FGFR2 | P21802 | 3/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | KIT | P10721 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23147176 | 1.00 | PDGFRB (0.54) | PDGFRBPDGFRAAXLFGFR2EGFR | |
| SCHEMBL4462225 | 0.86 | PDGFRA (0.56) | PDGFRBPDGFRAFGFR2EGFRKDR | |
| SCHEMBL22265563 | 0.85 | AXL (0.54) | PDGFRAAXLFGFR2KDRKIT | |
| SCHEMBL14967538 | 0.84 | PDGFRB (0.57) | PDGFRBPDGFRAAXLFGFR2EGFR | |
| SCHEMBL166914 | 0.83 | AXL (0.67) | PDGFRBPDGFRAAXLFGFR2KDR | |
| SCHEMBL17035605 | 0.82 | AXL (0.66) | PDGFRBPDGFRAAXLFGFR2KDR | |
| Hydrochloric Acid SCHEMBL30388215 | 0.82 | AXL (0.66) | PDGFRBPDGFRAAXLFGFR2KDR | |
| Hydrochloric Acid SCHEMBL21776567 | 0.82 | AXL (0.66) | PDGFRBPDGFRAAXLFGFR2KDR | |
| SCHEMBL31554494 | 0.82 | KIT (0.45) | PDGFRBPDGFRAEGFRKDRKIT | |
| SCHEMBL21753513 | 0.81 | PDGFRB (0.59) | PDGFRBPDGFRAFGFR2EGFRKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096463-A1 | PLK4 MODULATORS | VIBLIOME THERAPEUTICS, LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-114787144-A | Pyridone compounds and methods for modulating protein kinases | 埃克塞里艾克西斯公司 | 2022-07-22 | — | — | CN | disclosed |